The company is the first in the industry to be listed in July 2011 (stock code: 300244), realizing the "zero breakthrough" in the listing of independent medical laboratories in China, and maintaining a compound growth rate of more than 40% for six consecutive years.
Dian Diagnostics is committed to providing customers with "medical diagnostic services as a whole solution", and is actively promoting the expansion of the third-party independent medical diagnostic platform of multi-service areas and upstream and downstream industry chain integrated development strategy, business covers medical diagnostic services, diagnostic products and services marketing, forensic science, health examination business, The business covers medical diagnostic services, marketing of diagnostic products and services, forensic identification, health check business, cold chain logistics, R&D and production of diagnostic technology, CRO, and biological sample bank. At present, the company has 39 independent provincial medical laboratories across the country, and has successively passed the ISO15189 and CAP international quality certification and accreditation system, providing services to more than 22,000 medical institutions across the country.
Diane focuses on the innovation of diagnostic technology platform, and has been approved as a pilot unit of high-throughput gene sequencing technology for tumor diagnosis and treatment projects, a demonstration center for clinical application of gene testing technology, and a demonstration center for application of third-party high-performance medical diagnostic and treatment equipment. It has cooperated with Johns Hopkins University, American Forensic Science Institute, and the National Center for Medical Diagnostic and Treatment Applications. Hopkins University, the U.S. forensic identification agency NMS, the U.S. Department of Justice of Maryland, South Korea SCL Health Management Group and many other internationally renowned organizations to reach a strategic cooperation.
With the deepening of the new healthcare reform process, the aging of the society and the rise of personalized diagnosis and treatment, Dean will take advantage of the momentum of the vigorous development of the health service industry, give full play to the unique business model, innovative technology research and development, and improve the management system and other advantages, and take the mission of "letting the people of the country share the health equally" as its mission to build a large health industry ecosystem and achieve the goal of "creating a healthy environment for the people of the country", as well as to achieve the goal of "creating a healthy society". To create a large health industry ecosystem, to realize the win-win situation for medical institutions, government and people, and to become a respected company in the diagnostic industry. We are eagerly looking forward to as the future of the medical industry elite you to join us, in the realization of self-worth at the same time, to help China's new health care reform in-depth promotion, to contribute to the cause of social health, and Dean together with the rapid development.